Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical trials report. Chronic kidney disease: blood pressure, treatment goals, and cardiovascular outcomes.

Literature DB >> 12948433

Clinical trials report. Chronic kidney disease: blood pressure, treatment goals, and cardiovascular outcomes.

Matthew R Weir¹.

Abstract

Entities: Disease

Year: 2003 PMID： 12948433 DOI： 10.1007/s11906-003-0086-x

Source DB: PubMed Journal: Curr Hypertens Rep ISSN： 1522-6417 Impact factor: 5.369

× No keyword cloud information.

19 in total

1. Dynamic interaction between myogenic and TGF mechanisms in afferent arteriolar blood flow autoregulation.

Authors: M Walker; L M Harrison-Bernard; A K Cook; L G Navar
Journal: Am J Physiol Renal Physiol Date: 2000-11

2. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors:
Journal: Am J Kidney Dis Date: 2002-02 Impact factor: 8.860

3. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors:
Journal: JAMA Date: 2002-12-18 Impact factor: 56.272

4. Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients.

Authors: A Schmitz; M Vaeth
Journal: Diabet Med Date: 1988-03 Impact factor: 4.359

5. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors: H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal: JAMA Date: 2001-07-25 Impact factor: 56.272

6. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors: A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal: Ann Intern Med Date: 1999-03-16 Impact factor: 25.391

7. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease.

Authors: A S Levey; J A Beto; B E Coronado; G Eknoyan; R N Foley; B L Kasiske; M J Klag; L U Mailloux; C L Manske; K B Meyer; P S Parfrey; M A Pfeffer; N K Wenger; P W Wilson; J T Wright
Journal: Am J Kidney Dis Date: 1998-11 Impact factor: 8.860

Clinical trials report. Chronic kidney disease: blood pressure, treatment goals, and cardiovascular outcomes.

1. Dynamic interaction between myogenic and TGF mechanisms in afferent arteriolar blood flow autoregulation.

2. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

3. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

4. Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients.

5. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

6. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

7. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease.

8. Does renal dysfunction predict mortality after acute stroke? A 7-year follow-up study.

9. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.

10. The predictive value of microalbuminuria in IDDM. A five-year follow-up study.

1. Pharmacological interventions for heart failure in people with chronic kidney disease.